Fangfang Jie

Nanchang University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index95citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(4), Angiogenesis and VEGF in Cancer(3), Lung Cancer Research Studies(3), Lung Cancer Diagnosis and Treatment(2), Lung Cancer Treatments and Mutations(2)

Publications12 total

Research on Reservoir Drill-in and Completion Fluid with Unique Direct Backflow Property for Gravel-Packed Openhole Construction
Arabian Journal for Science and Engineering·2022· 3 cited
Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement
Medicine·2022· 7 citedOpen Access
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis
Tumori Journal·2022· 3 cited
An autonomously self-gel-breaking, highly reservoir protective completion fluid tailored for gel-free processing in multi-lateral well construction
Journal of Petroleum Science and Engineering·2022· 7 cited
Hydroxylated Derivatives of Methyl Oleate as Biobased Tribological Additives for Lubricants
International Journal of Surface Science and Engineering·2022
Hydroxylated derivatives of methyl oleate as biobased tribological additives for lubricants
International Journal of Surface Science and Engineering·2022
Endostar enhances anti-tumor effects of radiation via inhibition of HIF-1α and bFGF in lung adenocarcinoma cell line A549
The Chinese-German Journal of Clinical Oncology·2013· 2 cited
Endostar enhances the radioresponse on lewis lung carcinoma by regulating HIF-1α
2011· 2 cited
Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells
Molecular Biology Reports·2011· 44 cited
Clinical observation of pemetrexed on advanced non-small-cell lung cancer
The Chinese-German Journal of Clinical Oncology·2011· 2 cited
Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
PubMed·2011· 24 cited
Clinical observation of nedaplatin concurrent with radiotherapy for mid-advanced nasopharyngeal carcinoma and esophageal carcinoma
The Chinese-German Journal of Clinical Oncology·2010· 1 cited

Frequent Co-authors

Wei Ge(6), Changhu Li(3), Yongfa Zheng(3), Dedong Cao(3), Zhenyu Zhao(2), Lin Xu(2), Mingbiao Xu(2), Meilan Huang(2), Ling Zhang(2), Mingjia Liao(2), Chunyu Song(2), Chengli Tang(2), Boshui Chen(2), Ling Zhang(1), Ke Hu(1), Yanyan Zhang(1), Ximing Xu(1), He Du(1), Jinzhong Zhang(1), Yu Chen(1)